206 related articles for article (PubMed ID: 32532811)
1. Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Pilones KA; Charpentier M; Garcia-Martinez E; Daviaud C; Kraynak J; Aryankalayil J; Formenti SC; Demaria S
Cancer Immunol Res; 2020 Aug; 8(8):1054-1063. PubMed ID: 32532811
[TBL] [Abstract][Full Text] [Related]
2. Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.
Romano E; Rossi M; Ratzinger G; de Cos MA; Chung DJ; Panageas KS; Wolchok JD; Houghton AN; Chapman PB; Heller G; Yuan J; Young JW
Clin Cancer Res; 2011 Apr; 17(7):1984-97. PubMed ID: 21355077
[TBL] [Abstract][Full Text] [Related]
3. The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells.
Ye JF; Qi WX; Liu MY; Li Y
Cell Immunol; 2017 Aug; 318():35-41. PubMed ID: 28651743
[TBL] [Abstract][Full Text] [Related]
4. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
5. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
6. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance.
Doedens AL; Rubinstein MP; Gross ET; Best JA; Craig DH; Baker MK; Cole DJ; Bui JD; Goldrath AW
Cancer Immunol Res; 2016 Sep; 4(9):799-811. PubMed ID: 27485135
[TBL] [Abstract][Full Text] [Related]
7. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
8. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel JC; Crozat K; Dalod M; Mattiuz R
Front Immunol; 2019; 10():9. PubMed ID: 30809220
[TBL] [Abstract][Full Text] [Related]
9. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
[TBL] [Abstract][Full Text] [Related]
10. IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection.
Pilones KA; Charpentier M; Garcia-Martinez E; Demaria S
Oncoimmunology; 2020 Jul; 9(1):1790716. PubMed ID: 32934886
[TBL] [Abstract][Full Text] [Related]
11. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.
Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S
Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J
Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533
[TBL] [Abstract][Full Text] [Related]
13. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.
Giampazolias E; Schulz O; Lim KHJ; Rogers NC; Chakravarty P; Srinivasan N; Gordon O; Cardoso A; Buck MD; Poirier EZ; Canton J; Zelenay S; Sammicheli S; Moncaut N; Varsani-Brown S; Rosewell I; Reis e Sousa C
Cell; 2021 Jul; 184(15):4016-4031.e22. PubMed ID: 34081922
[TBL] [Abstract][Full Text] [Related]
14. Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.
Blair TC; Bambina S; Alice AF; Kramer GF; Medler TR; Baird JR; Broz ML; Tormoen GW; Troesch V; Crittenden MR; Gough MJ
J Immunol; 2020 Jun; 204(12):3416-3424. PubMed ID: 32341058
[TBL] [Abstract][Full Text] [Related]
15. NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells.
Iraolagoitia XL; Spallanzani RG; Torres NI; Araya RE; Ziblat A; Domaica CI; Sierra JM; Nuñez SY; Secchiari F; Gajewski TF; Zwirner NW; Fuertes MB
J Immunol; 2016 Aug; 197(3):953-61. PubMed ID: 27342842
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Antitumor Activity of a Recombinant IL7/IL15 Hybrid Cytokine in Mice.
Song Y; Liu Y; Hu R; Su M; Rood D; Lai L
Mol Cancer Ther; 2016 Oct; 15(10):2413-2421. PubMed ID: 27474151
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord blood-derived mesenchymal stem cells producing IL15 eradicate established pancreatic tumor in syngeneic mice.
Jing W; Chen Y; Lu L; Hu X; Shao C; Zhang Y; Zhou X; Zhou Y; Wu L; Liu R; Fan K; Jin G
Mol Cancer Ther; 2014 Aug; 13(8):2127-37. PubMed ID: 24928851
[TBL] [Abstract][Full Text] [Related]
18. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
[TBL] [Abstract][Full Text] [Related]
19. CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection.
Wennerberg E; Spada S; Rudqvist NP; Lhuillier C; Gruber S; Chen Q; Zhang F; Zhou XK; Gross SS; Formenti SC; Demaria S
Cancer Immunol Res; 2020 Apr; 8(4):465-478. PubMed ID: 32047024
[TBL] [Abstract][Full Text] [Related]
20. IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy.
Pilipow K; Roberto A; Roederer M; Waldmann TA; Mavilio D; Lugli E
Cancer Res; 2015 Dec; 75(24):5187-5193. PubMed ID: 26627006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]